Building a Separate House for Oncology Assets https://buff.ly/2CkVQfK #oncology #immunotherapies #joint-venture… https://twitter.com/i/web/status/1193990029279973381

Early Lung Cancer Detection Followed by Minimally Invasive Surgery Saves Lives https://www.ascopost.com/issues/november-10-2019/early-lung-cancer-detection-followed-by-minimally-invasive-surgery-saves-lives/ #lcsm #oncology #cancer #screening

Game changer? #cancer #oncology The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity https://buff.ly/2JK0BUc

Third-Line Cabazitaxel Improves Outcomes in Patients With Metastatic Prostate Cancer https://www.ascopost.com/issues/november-10-2019/third-line-cabazitaxel-improves-outcomes-in-patients-with-metastatic-prostate-cancer/ #pcsm #oncology #cancer #ESMO19

IMvigor130 Trial: Atezolizumab Plus Chemotherapy for Metastatic Urothelial Cancer https://www.ascopost.com/issues/november-10-2019/atezolizumab-plus-chemotherapy-for-metastatic-urothelial-cancer/ #blcsm #oncology #cancer

We’re pleased to share our latest update in #oncology. Learn more here: http://merck.us/2Ob1hU3 $MRK https://t.co/BEcNqpZ0Y0

New lecture "Lung Cancer: Preparing for the Unknown" https://youtu.be/kcU1l9kx7x0 #lungcancer #oncology #cancer… https://twitter.com/i/web/status/1195017715406295042

https://www.rikelab.jp/study/5930 UJA快調こと佐々木敦朗さんのがん研究に関するインタビューです。共同研究者とのやり取りのコツやUJAについても触れられています!　#UJA_info #研究成果　#oncology… https://twitter.com/i/web/status/1193880831913267206

Veliparib Plus Chemotherapy Meets Primary Endpoint in Advanced Ovarian Cancer https://www.ascopost.com/news/november-2019/veliparib-plus-chemotherapy-meets-primary-endpoint-in-advanced-ovarian-cancer/ #gyncsm #oncology #cancer

A Third Shot at #EGFR: New Opportunities in #Cancer #Therapy. - PubMed - NCBI https://www.ncbi.nlm.nih.gov/pubmed/31706618 #oncology